- Joined
- 1 January 2008
- Posts
- 123
- Reactions
- 0
Stock dropped 62% today! Ann stated (Sorry don't know how to put link into post) USFDA rejected application. Just before SPP offer 25 Jan! What a blow!
Update today
"SBL has provided supporting documentation regarding FDA
regulations for forensic use and SBL CE marking documentation and an initial purchase of 2,000 units
has been shipped to Mexico."
A good start??
A very good question and I am wondering the same thing. Have been digging and cant put it down to anything either. That said this share has moved before prier to releasing information so perhaps news is on the way again.Hi,
Just wondering whether someone could tell me, am I missing something with SBN recently.
Their share price has increased 7.14% Friday and another 30% today. The volume of buyers is 12 808 362 to sellers 3 671 100.
I have researched and have not found any information that indicates any announcements out soon or new developments:-
Bioscreens - Urine drug screening device to be launched in US testing market in quarter ending Septmeber 2008
Visualine - have lowered cost of manufacturing and will be ready to be relaunched in a reduced product selling price in quarter June 2008
Mexico - SBN is unable to make any prediction regarding the outcome....if and when it might expand beyond the intial pilot
Russia - marketing of Oraline IV in Russia....it is anticipated that approval can be obtained within 8 months
China - is currently in stage 1 of the agreement. (No other timelines given)
As you can see there is nothing that I can tell that should be driving the market at this time.
The only other two factors it may be is their website was launched in March 2008 so maybe perhaps exposure and a meeting is being held on May 14th to get approval for 21 235 000 shares to be issued at 4.3 cents so maybe people believe that any price below that is good.
Any opinions or other information that I have missed would be good?
Cheers.
Hi Mates! Is any one holding thi stock. I came across few months ago and thinking to jump in. It is quiet cheap.
Just last week, Dimerix issued $20 million worth of new shares to institutional investors at 20¢ each to leave them sitting on an instant $20 million paper profit today.On Monday, penny stock biotech Dimerix opened 70 per cent higher at 40¢ after being recommended by online stock tipping website Next Investors.
StocksDigital, the financial media business behind Next Investors and Wise Owl, freely admits to investing in businesses before making public recommendations.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?